Skip to main content
Clinical Trials/JPRN-jRCT1010230018
JPRN-jRCT1010230018
Not yet recruiting
未知

A PrOsPectve cohort study on interstitial Lung disease-Associated pulmonary hypertension with a particulaR focus on the subset with pulmonary arterial hypertension-feature - POPLAR study

Tsujino Ichizo0 sites250 target enrollmentJuly 8, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Pulmonary hypertension, Interstitial lung disease
Sponsor
Tsujino Ichizo
Enrollment
250
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 8, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Tsujino Ichizo

Eligibility Criteria

Inclusion Criteria

  • 1\.Male or female who are \>\=20 years of age at the time of initial PH or ILD diagnosis.
  • 2\.With a diagnosis of PAH, ILD\-PH, or ILD\-no PH at the time of study entry
  • 3\.Individuals who voluntarily consent to participate in the study with sufficient understanding after receiving a detailed explanation of it

Exclusion Criteria

  • 1\.Patients who are diagnosed with PH, but classified as group 2, 4, or 5
  • 2\.Patients who are classified as group 3 PH without PAH, but have received medication for PAH before baseline
  • 3\.Patients who are diagnosed with ILD, the state of which is however expected to change rapidly, including respiratory infection, and drug\-induced pneumonia
  • 4\.\[Prevalent patient only] patients whose first ILD or PH diagnosis was before January 1, 2010\.
  • 5\.Other individuals who, in the opinion of the sponsor, are not appropriate patients

Outcomes

Primary Outcomes

Not specified

Similar Trials